Comparison Between Antineoplastic Treatments With Selective Inhibitors (BRAF MEK) and the New Potentials Combinatorial Therapies for Metastatic Melanoma. RSD 2022, 11 (14), e326111436275. https://doi.org/10.33448/rsd-v11i14.36275.